# When Postoperative Inflammation Isn’t Benign: Thyroid Eye Disease Following Cataract Surgery

**Authors:** Yilynn Chiew, Khay Wei Poh

PMC · DOI: 10.7759/cureus.95196 · Cureus · 2025-10-22

## TL;DR

A rare case of thyroid eye disease developing after cataract surgery highlights the need for early diagnosis to prevent vision loss.

## Contribution

Reports a rare clinical case linking cataract surgery with thyroid eye disease onset.

## Key findings

- TED can develop after cataract surgery, even in the absence of overt thyroid dysfunction.
- Delayed diagnosis of TED after surgery can lead to severe visual complications.
- Treatment with steroids, immunosuppressants, and decompression surgery improved the patient's condition.

## Abstract

Thyroid eye disease (TED) is an autoimmune inflammatory disorder of the orbital tissues, most commonly associated with Graves’ hyperthyroidism. Although it typically occurs in the presence of thyroid dysfunction, TED may also arise in euthyroid or subclinical states. Its onset after ocular surgery is uncommon and may mimic routine postoperative inflammation, delaying diagnosis. A 67-year-old Chinese-Malaysian man developed eyelid swelling, redness, and blurred vision two weeks after uncomplicated left-eye cataract surgery. He was initially treated for common postoperative complications, but his condition progressively worsened, with visual acuity declining from 6/12 (6/9 with pinhole preoperatively) to 6/30 without pinhole improvement over six months, accompanied by proptosis, diplopia, and optic nerve dysfunction. Laboratory tests revealed subclinical hyperthyroidism, and orbital contrast-enhanced computed tomography confirmed tendon-sparing enlargement of all extraocular muscles, consistent with sight-threatening TED. He received intravenous methylprednisolone, mycophenolate mofetil, and carbimazole, followed by urgent medial wall decompression due to worsening optic neuropathy, with subsequent visual improvement. TED following cataract surgery is rare but underscores the importance of considering atypical postoperative courses. Early recognition and adherence to guideline-based management are crucial to preserve vision.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741), mycophenolate mofetil (PubChem CID 5281078), carbimazole (PubChem CID 31072)
- **Diseases:** Thyroid eye disease (MONDO:0001509), Graves’ hyperthyroidism (MONDO:0005364)

## Full-text entities

- **Diseases:** Cataract (MESH:D002386), thyroid dysfunction (MESH:D013959), optic nerve dysfunction (MESH:D000080344), Inflammation (MESH:D007249), proptosis (MESH:D005094), blurred vision (MESH:D014786), Graves' hyperthyroidism (MESH:D006980), TED (MESH:D049970), diplopia (MESH:D004172), eyelid swelling (MESH:D005141), optic neuropathy (MESH:D009901)
- **Chemicals:** carbimazole (MESH:D002231), mycophenolate mofetil (MESH:D009173), methylprednisolone (MESH:D008775)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12638460/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12638460/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12638460/full.md

---
Source: https://tomesphere.com/paper/PMC12638460